During the past decade, Middle Tennessee Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middle Tennessee Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Middle Tennessee Clinical Research" are "Migraine, With or Without Aura" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetes" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Middle Tennessee Clinical Research" in a lesser frequency.

Most popular intervention types in "Middle Tennessee Clinical Research" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Dapagliflozin" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Middle Tennessee Clinical Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Middle Tennessee Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Middle Tennessee Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Middle Tennessee Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".